4 Firms Steer BioNTech's Downsized $150M IPO
German drug developer BioNTech SE on Thursday completed a $150 million U.S. initial public offering steered by four law firms, raising less money than it originally hoped to in order to...To view the full article, register now.
Already a subscriber? Click here to view full article